Alastin has receives two new patents for technology related to TransFORM Body Treatment, bringing them to six patents in the U.S., and a seventh patent in Canada. The first patent covers Alastin’s platform TriHex Technology and while the second relates to liposomal compositions both associated with TransFORM Body Treatment. These new patents are directed to methods for the use of topical compositions of TransFORM Body Treatment with TriHex Technology to improve skin laxity, texture or crepiness, with or without body contouring procedures or for targeting dermal white adipose tissue. "We are immensely proud of the scientific rigor we have established in validating the TriHex Technology performance in our product formulations, which is confirmed by our numerous patents," says Dr. Alan Widgerow, chief medical officer at Alastin. "This is particularly relevant to this TransFORM Body product where disruptive new science has allowed us to make great progress in aiding skin tightening and body contouring."
Related Articles
Alastin Skincare Publishes New Study Findings About TransFORM
Ideal Image Partners With Alastin Skincare and EltaMD